Effective myotube formation in human adipose tissue-derived stem cells expressing dystrophin and myosin heavy chain by cellular fusion with mouse C2C12 myoblasts

Biochemical and Biophysical Research Communications

Volumn 408, Issue 1, 2011, Pages 167-173

  Eom, Young Woo ^a,b   Lee, Jong Eun ^b   Yang, Mal Sook ^b   Jang, In Keun ^b   Kim, Hyo Eun ^b   Lee, Doo Hoon ^b   Kim, Young Jin ^b   Park, Won Jin ^c   Kong, Jee Hyun ^a   Shim, Kwang Yong ^a   Lee, Jong In ^a   Kim, Hyun Soo ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

^b Biomedical Research Institute   (South Korea)

^c Dr Park's Reset Clinic   (South Korea)

Author keywords

Adipose tissue derived stem cell; Dystrophin; Muscular dystrophy; Myosin heavy chain; Myotube

Indexed keywords

AZACITIDINE; DYSTROPHIN; FIBROBLAST GROWTH FACTOR 2; MYOD PROTEIN; MYOGENIN; MYOSIN HEAVY CHAIN;

ADIPOSE TISSUE CELL; ADULT; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL FUSION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL;

ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; CELL FUSION; CELL LINE; CELL LINEAGE; COCULTURE TECHNIQUES; DYSTROPHIN; HUMANS; MICE; MUSCLE DEVELOPMENT; MUSCLE FIBERS, SKELETAL; MYOBLASTS; MYOSIN HEAVY CHAINS; REGENERATION; STEM CELLS;

EID: 79955366016     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.04.002     Document Type: Article

References (28)

1. Lapidos K.A., Kakkar R., McNally E.M. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ. Res. 2004, 94:1023-1031.
2. Wolff J.A., Ludtke J.J., Acsadi G., Williams P., Jani A. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1992, 1:363-369.
3. Watchko J., O'Day T., Wang B., Zhou L., Tang Y., Li J., Xiao X. Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice. Hum. Gene Ther. 2002, 13:1451-1460.
4. Kren B.T., Bandyopadhyay P., Steer C.J. In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides. Nat. Med. 1998, 4:285-290.
5. Santana E., Peritz A.E., Iyer S., Uitto J., Yoon K. Different frequency of gene targeting events by the RNA-DNA oligonucleotide among epithelial cells. J. Invest. Dermatol. 1998, 111:1172-1177.
6. Partridge T.A., Morgan J.E., Coulton G.R., Hoffman E.P., Kunkel L.M. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 1989, 337:176-179.
7. Gussoni E., Soneoka Y., Strickland C.D., Buzney E.A., Khan M.K., Flint A.F., Kunkel L.M., Mulligan R.C. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999, 401:390-394.
8. Asakura A., Seale P., Girgis-Gabardo A., Rudnicki M.A. Myogenic specification of side population cells in skeletal muscle. J. Cell Biol. 2002, 159:123-134.
9. Burton E.A., Tinsley J.M., Holzfeind P.J., Rodrigues N.R., Davies K.E. A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy. Proc. Natl. Acad. Sci. USA 1999, 96:14025-14030.
10. Gramolini A.O., Burton E.A., Tinsley J.M., Ferns M.J., Cartaud A., Cartaud J., Davies K.E., Lunde J.A., Jasmin B.J. Muscle and neural isoforms of agrin increase utrophin expression in cultured myotubes via a transcriptional regulatory mechanism. J. Biol. Chem. 1998, 273:736-743.
11. Mouly V., Aamiri A., Perie S., Mamchaoui K., Barani A., Bigot A., Bouazza B., Francois V., Furling D., Jacquemin V., Negroni E., Riederer I., Vignaud A., St Guily J.L., Butler-Browne G.S. Myoblast transfer therapy: is there any light at the end of the tunnel?. Acta Myol. 2005, 24:128-133.
12. Cossu G., Sampaolesi M. New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials. Trends Mol. Med. 2007, 13:520-526.
13. Meng J., Muntoni F., Morgan J.E. Stem cells to treat muscular dystrophies - where are we?. Neuromuscul. Disord. 2011, 21:4-12.
14. Gotherstrom C. Immunomodulation by multipotent mesenchymal stromal cells. Transplantation 2007, 84:S35-S37.
15. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
16. Ichim T.E., Alexandrescu D.T., Solano F., Lara F., Campion Rde N., Paris E., Woods E.J., Murphy M.P., Dasanu C.A., Patel A.N., Marleau A.M., Leal A., Riordan N.H. Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy. Cell. Immunol. 2010, 260:75-82.
17. Kuznetsov S.A., Mankani M.H., Gronthos S., Satomura K., Bianco P., Robey P.G. Circulating skeletal stem cells. J. Cell Biol. 2001, 153:1133-1140.
18. Jiang Y., Vaessen B., Lenvik T., Blackstad M., Reyes M., Verfaillie C.M. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp. Hematol. 2002, 30:896-904.
19. De Ugarte D.A., Morizono K., Elbarbary A., Alfonso Z., Zuk P.A., Zhu M., Dragoo J.L., Ashjian P., Thomas B., Benhaim P., Chen I., Fraser J., Hedrick M.H. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003, 174:101-109.
20. Sakaguchi Y., Sekiya I., Yagishita K., Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 2005, 52:2521-2529.
21. Di Rocco G., Iachininoto M.G., Tritarelli A., Straino S., Zacheo A., Germani A., Crea F., Capogrossi M.C. Myogenic potential of adipose-tissue-derived cells. J. Cell Sci. 2006, 119:2945-2952.
22. Vieira N.M., Brandalise V., Zucconi E., Jazedje T., Secco M., Nunes V.A., Strauss B.E., Vainzof M., Zatz M. Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro. Biol. Cell 2008, 100:231-241.
23. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., Benhaim P., Lorenz H.P., Hedrick M.H. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001, 7:211-228.
24. Dezawa M., Ishikawa H., Itokazu Y., Yoshihara T., Hoshino M., Takeda S., Ide C., Nabeshima Y. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 2005, 309:314-317.
25. Wakitani S., Saito T., Caplan A.I. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995, 18:1417-1426.
26. Gang E.J., Jeong J.A., Hong S.H., Hwang S.H., Kim S.W., Yang I.H., Ahn C., Han H., Kim H. Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood. Stem Cells 2004, 22:617-624.
27. Gorbe A., Becker D.L., Dux L., Krenacs L., Krenacs T. In differentiating perfusion myoblasts connexin43 gap junction coupling is upregulated before myoblast alignment then reduced in post-mitotic cells. Histochem. Cell Biol. 2006, 125:705-716.
28. Chan J., O'Donoghue K., Gavina M., Torrente Y., Kennea N., Mehmet H., Stewart H., Watt D.J., Morgan J.E., Fisk N.M. Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration. Stem Cells 2006, 24:1879-1891.